Mengying Hu

2.7k total citations · 2 hit papers
45 papers, 2.0k citations indexed

About

Mengying Hu is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Mengying Hu has authored 45 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 13 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Mengying Hu's work include Nanoparticle-Based Drug Delivery (9 papers), Immunotherapy and Immune Responses (7 papers) and Nanoplatforms for cancer theranostics (7 papers). Mengying Hu is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), Immunotherapy and Immune Responses (7 papers) and Nanoplatforms for cancer theranostics (7 papers). Mengying Hu collaborates with scholars based in China, United States and Singapore. Mengying Hu's co-authors include Leaf Huang, Zhuo Yu, Jianfeng Guo, Yueqiu Gao, Rihe Liu, Ying Wang, Limei Shen, Wantong Song, Sai An and Menglin Wang and has published in prestigious journals such as Advanced Materials, Nature Communications and ACS Nano.

In The Last Decade

Mengying Hu

45 papers receiving 2.0k citations

Hit Papers

Icaritin Exacerbates Mitophagy and Synergizes with Doxoru... 2020 2026 2022 2024 2020 2024 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengying Hu China 24 733 579 576 413 347 45 2.0k
Xianhuo Wang China 30 1.0k 1.4× 252 0.4× 387 0.7× 417 1.0× 697 2.0× 101 3.0k
Zhuo Yu China 27 938 1.3× 654 1.1× 478 0.8× 436 1.1× 365 1.1× 81 2.7k
Na Shen China 27 986 1.3× 325 0.6× 698 1.2× 310 0.8× 470 1.4× 79 2.2k
Gaofeng Shu China 29 775 1.1× 251 0.4× 933 1.6× 138 0.3× 510 1.5× 68 2.8k
Yongfang Yuan China 26 1.1k 1.6× 217 0.4× 733 1.3× 162 0.4× 587 1.7× 77 3.1k
Guanyu Chen China 24 703 1.0× 445 0.8× 229 0.4× 364 0.9× 206 0.6× 93 1.8k
Linjiang Song China 27 1.1k 1.5× 271 0.5× 304 0.5× 247 0.6× 289 0.8× 75 2.1k
Xuemei Huang China 24 795 1.1× 318 0.5× 173 0.3× 202 0.5× 202 0.6× 70 2.1k
Ling Zhao China 32 1.0k 1.4× 149 0.3× 472 0.8× 340 0.8× 659 1.9× 95 2.7k

Countries citing papers authored by Mengying Hu

Since Specialization
Citations

This map shows the geographic impact of Mengying Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengying Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengying Hu more than expected).

Fields of papers citing papers by Mengying Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengying Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengying Hu. The network helps show where Mengying Hu may publish in the future.

Co-authorship network of co-authors of Mengying Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Mengying Hu. A scholar is included among the top collaborators of Mengying Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengying Hu. Mengying Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
You, Changxuan, Ping Ye, Li Zhang, et al.. (2025). LncRNA 4933431K23Rik modulate microglial phenotype via inhibiting miR-10a-5p in spinal cord injury induced neuropathic pain. Scientific Reports. 15(1). 11620–11620. 2 indexed citations
2.
Wang, Ying, Sirui Li, Mengying Hu, et al.. (2024). Universal STING mimic boosts antitumour immunity via preferential activation of tumour control signalling pathways. Nature Nanotechnology. 19(6). 856–866. 51 indexed citations breakdown →
3.
Zhang, Xiaohui, Lingfei Kong, Yutong Kang, et al.. (2023). Lipid Mediators Metabolic Chaos of Asthmatic Mice Reversed by Rosmarinic Acid. Molecules. 28(9). 3827–3827. 1 indexed citations
4.
Lin, Jinrong, et al.. (2023). Integration of network pharmacology, transcriptomics and molecular docking reveals two novel hypoglycemic components in snow chrysanthemum. Biomedicine & Pharmacotherapy. 163. 114818–114818. 6 indexed citations
5.
Hu, Mengying, Candia M. Kenific, Nancy Boudreau, & David Lyden. (2023). Tumor-derived nanoseeds condition the soil for metastatic organotropism. Seminars in Cancer Biology. 93. 70–82. 32 indexed citations
6.
Li, Zhongchi, Vivien Low, Valbona Luga, et al.. (2022). Tumor-produced and aging-associated oncometabolite methylmalonic acid promotes cancer-associated fibroblast activation to drive metastatic progression. Nature Communications. 13(1). 6239–6239. 44 indexed citations
7.
Hu, Mengying & Leaf Huang. (2022). Strategies targeting tumor immune and stromal microenvironment and their clinical relevance. Advanced Drug Delivery Reviews. 183. 114137–114137. 44 indexed citations
8.
Liu, Xiaoyu, Jingying Zhou, Haoran Wu, et al.. (2022). Fibrotic immune microenvironment remodeling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma. Molecular Therapy. 31(1). 119–133. 20 indexed citations
9.
Sendi, Hossein, Mostafa Yazdimamaghani, Mengying Hu, et al.. (2021). Nanoparticle Delivery of miR-122 Inhibits Colorectal Cancer Liver Metastasis. Cancer Research. 82(1). 105–113. 53 indexed citations
10.
Hu, Mengying, Ying Wang, Zhengsheng Liu, et al.. (2021). Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis. Nature Nanotechnology. 16(4). 466–477. 105 indexed citations
11.
Xu, Huan, Mengying Hu, Mengrui Liu, et al.. (2020). Nano-puerarin regulates tumor microenvironment and facilitates chemo- and immunotherapy in murine triple negative breast cancer model. Biomaterials. 235. 119769–119769. 141 indexed citations
12.
Yu, Wen, Yichun Zhu, Miao Wang, et al.. (2020). Preparation of porous silicate supported micro-nano zero-valent iron from copper slag and used as persulfate activator for removing organic contaminants. The Science of The Total Environment. 754. 142131–142131. 52 indexed citations
13.
Qiu, Nasha, Yun Liu, Qi Liu, et al.. (2020). Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy. Biomaterials. 269. 120604–120604. 77 indexed citations
14.
Hu, Mengying, et al.. (2019). Relaxin-FOLFOX-IL-12 triple combination therapy engages memory response and achieves long-term survival in colorectal cancer liver metastasis. Journal of Controlled Release. 319. 213–221. 20 indexed citations
15.
Hu, Mengying, Ying Wang, Ligeng Xu, et al.. (2019). Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy. Nature Communications. 10(1). 2993–2993. 104 indexed citations
17.
Hu, Mengying & Leaf Huang. (2018). Nanomaterial Manipulation of Immune Microenvironment in the Diseased Liver. Advanced Functional Materials. 29(7). 15 indexed citations
18.
19.
Zhao, Jun, Hongtao Jin, Yan Cao, et al.. (2013). Vasorelaxant effects of the extracts and some flavonoids from the buds ofCoreopsis tinctoria. Pharmaceutical Biology. 51(9). 1158–1164. 39 indexed citations
20.
Aisa, Haji Akber, Xuelei Xin, Yan Mao, et al.. (2012). Hepatoprotective activities of a sesquiterpene-rich fraction from the aerial part of Cichorium glandulosum. Chinese Medicine. 7(1). 21–21. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026